Brookline Capital Management started coverage on shares of Envoy Medical (NASDAQ:COCH – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage issued a buy rating and a $9.00 target price on the stock.
Separately, Ascendiant Capital Markets raised their target price on shares of Envoy Medical from $8.50 to $8.75 and gave the stock a buy rating in a research report on Tuesday, September 3rd.
View Our Latest Stock Analysis on COCH
Envoy Medical Stock Performance
Envoy Medical (NASDAQ:COCH – Get Free Report) last posted its earnings results on Monday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The firm had revenue of $0.07 million during the quarter, compared to analysts’ expectations of $0.08 million. As a group, analysts forecast that Envoy Medical will post -1.22 EPS for the current fiscal year.
Hedge Funds Weigh In On Envoy Medical
A hedge fund recently bought a new stake in Envoy Medical stock. WealthTrust Asset Management LLC purchased a new position in Envoy Medical, Inc. (NASDAQ:COCH – Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 11,316 shares of the company’s stock, valued at approximately $44,000. WealthTrust Asset Management LLC owned approximately 0.06% of Envoy Medical at the end of the most recent reporting period. 8.59% of the stock is owned by institutional investors and hedge funds.
Envoy Medical Company Profile
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
See Also
- Five stocks we like better than Envoy Medical
- Options Trading – Understanding Strike Price
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- Stock Sentiment Analysis: How it Works
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.